FIONA HANLY: Open Payments
NPI 1265749345 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,669 in 115 payments from 23 companies in 2025. Trend: 2023 $2,255 · 2024 $1,622 · 2025 $3,669
Food & beverage: $2,169Consulting: $1,455Education: $46
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,455 |
| Galderma Laboratories, L.P. | 26 | $293 |
| Botanix SB Inc | 8 | $183 |
| Lilly USA, LLC | 5 | $183 |
| Organon LLC | 13 | $166 |
| Amgen Inc. | 11 | $165 |
| Regeneron Healthcare Solutions, Inc. | 5 | $154 |
| ABBVIE INC. | 8 | $144 |
| E.R. Squibb & Sons, L.L.C. | 4 | $127 |
| Novartis Pharmaceuticals Corporation | 7 | $125 |
Products named: DUPIXENT, SOFDRA, VTAMA, OTEZLA, NEMLUVIO, SKYRIZI, Sotyktu, EBGLYSS.
Industry payments across AZ — which companies pay providers there.
